AI
Healthcare & Life Sciences
Angiocrine Bioscience Inc
United Statesangiocrinebioscience.com
Angiocrine Bioscience Inc is a Healthcare & Life Sciences startup based in the United States, most recent round Series C.
Activeseries-c
series-c
Stage
About Angiocrine Bioscience Inc
Angiocrine Bioscience Inc is a startup based in the United States. Its most recent tracked round is Series C. Brouky classifies it under Healthcare & Life Sciences.
Angiocrine Bioscience is a clinical stage cell and gene therapy company developing therapies based on endothelial cell-derived angiocrine factors to guide progenitor cells, with its lead program in phase 3 trials targeting severe toxicities in hematological cancer patients undergoing hematopoietic cell transplantation.
Explore Angiocrine Bioscience Inc's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.